Literature DB >> 12864891

Nephrology in South East Asia: fact and concept.

Visith Sitprija1.   

Abstract

The developing countries of South East Asia lie within the tropics. Renal disease in this region represents the interaction between the kidney and the environment abetted by low levels of socioeconomic development in many areas. Together with genetic susceptibility to some diseases, there are widespread infectious diseases and prominently encountered plant and animal toxins. Chronic renal failure, most commonly the outcome of chronic glomerulonephritis and frequently to persistent nephrolithiasis as well as acute renal failure due to a variety of stimuli, are among the most common renal problems encountered. Renal replacement therapy is both a clinical and economic problem. The epidemiology of renal disease in the region is poorly understood, and workforce and treatment facilities are not adequate for the caseload in a number of countries in the region. Many people with chronic renal disease simply cannot afford the necessary treatment. The principle focus for the future must be on prevention strategies and the provision of appropriate health services within the current economic and technological restraints.

Entities:  

Mesh:

Year:  2003        PMID: 12864891     DOI: 10.1046/j.1523-1755.63.s83.27.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  8 in total

1.  Socioeconomic disadvantage and kidney disease in the United States, Australia, and Thailand.

Authors:  Sarah L White; Kevin McGeechan; Michael Jones; Alan Cass; Steven J Chadban; Kevan R Polkinghorne; Vlado Perkovic; Paul J Roderick
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

2.  Epidemiological trends in urolithiasis: impact on our health care systems.

Authors:  Alberto Trinchieri
Journal:  Urol Res       Date:  2006-01-27

3.  Etiological profile of nephrotic syndrome in Kashmir.

Authors:  A R Reshi; M A Bhat; M S Najar; K A Banday; M A Naik; D P Singh; F Wani
Journal:  Indian J Nephrol       Date:  2008-01

4.  How can we achieve global equity in provision of renal replacement therapy?

Authors:  Sarah L White; Steven J Chadban; Stephen Jan; Jeremy R Chapman; Alan Cass
Journal:  Bull World Health Organ       Date:  2008-03       Impact factor: 9.408

5.  The gap between estimated incidence of end-stage renal disease and use of therapy.

Authors:  Shuchi Anand; Asaf Bitton; Thomas Gaziano
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

6.  Acute Kidney Injury Recognition in Low- and Middle-Income Countries.

Authors:  Jorge Cerdá; Sumit Mohan; Guillermo Garcia-Garcia; Vivekanand Jha; Srinivas Samavedam; Swarnalata Gowrishankar; Arvind Bagga; Rajasekara Chakravarthi; Ravindra Mehta
Journal:  Kidney Int Rep       Date:  2017-04-25

7.  Demographics, Cost, and Sustainability of Haemodialysis among End-Stage Kidney Disease Patients in Southern Nigeria: A Single-Center Study.

Authors:  Effiong E Akpan; Udeme E Ekrikpo; Emmanuel Edet Effa; Aniema I A Udo; Victor A Umoh
Journal:  Niger Med J       Date:  2020-12-19

8.  The global nephrology workforce: emerging threats and potential solutions!

Authors:  Muhammad U Sharif; Mohamed E Elsayed; Austin G Stack
Journal:  Clin Kidney J       Date:  2015-11-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.